Doximity, Inc.

DOCSNYSECIK 1516513Technology / IT Servicesfiscal year ends March26 quarters since 2020

Revenue, Q2 FY2027
$175M
+3.6% on Q2 FY2026
Net income
$35M
−44.0% on Q2 FY2026
Free cash flow
$93M
−0.7% on Q2 FY2026
Diluted EPS
$0.18
−41.9% on Q2 FY2026
Revenue, TTM
$662M
trailing four quarters
Net margin, TTM
21.1%
net income $140M
Free cash flow, TTM
—
Cash and equivalents
$219M
long-term debt —, Sep 30, 2026
Shares, 12-month change
−6.5%
188M diluted weighted shares (no single count on the cover), Sep 30, 2026
Buybacks, TTM
$433M
6.9% of market value
Dividends, TTM
—
no yield
Market value
$6.3B
at the close, buybacks

Latest quarter Q2 FY2027, filed November 5, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2027, the quarter ended September 30, 2026, Doximity, Inc. reported revenue of $175M, +3.6% on Q2 FY2026, and net income of $35M (−44.0%). Operating margin was 25.2%. Free cash flow, operating cash flow less capital expenditures, was $93M ($93M less $0). Diluted earnings per share were $0.18.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

DOCS daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $33.51 · H $33.71 · L $32.79 · C $33.34 · +0.42% on the dayOver the range: −32.94%, Nov 14, 2025 to Nov 13, 2026
$15$25$35$44$54Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q3 FY2023 to Q2 FY2027, through the filing of November 5, 2026.

Revenue and net incomeRevenueNet income
$0$50M$100M$150M$200MQ3'23, Revenue: $115MQ3'23, Net income: $33MQ3'23Q4'23, Revenue: $111MQ4'23, Net income: $31MQ4'23Q1'24, Revenue: $108MQ1'24, Net income: $28MQ1'24Q2'24, Revenue: $114MQ2'24, Net income: $31MQ2'24Q3'24, Revenue: $135MQ3'24, Net income: $48MQ3'24Q4'24, Revenue: $118MQ4'24, Net income: $41MQ4'24Q1'25, Revenue: $127MQ1'25, Net income: $41MQ1'25Q2'25, Revenue: $137MQ2'25, Net income: $44MQ2'25Q3'25, Revenue: $169MQ3'25, Net income: $75MQ3'25Q4'25, Revenue: $138MQ4'25, Net income: $62MQ4'25Q1'26, Revenue: $146MQ1'26, Net income: $53MQ1'26Q2'26, Revenue: $169MQ2'26, Net income: $62MQ2'26Q3'26, Revenue: $185MQ3'26, Net income: $62MQ3'26Q4'26, Revenue: $145MQ4'26, Net income: $19MQ4'26Q1'27, Revenue: $157MQ1'27, Net income: $24MQ1'27Q2'27, Revenue: $175MQ2'27, Net income: $35MQ2'27$0$50M$100M$150M$200MQ3'23, Revenue: $115MQ3'23, Net income: $33MQ3'23Q4'23, Revenue: $111MQ4'23, Net income: $31MQ4'23Q1'24, Revenue: $108MQ1'24, Net income: $28MQ1'24Q2'24, Revenue: $114MQ2'24, Net income: $31MQ2'24Q3'24, Revenue: $135MQ3'24, Net income: $48MQ3'24Q4'24, Revenue: $118MQ4'24, Net income: $41MQ4'24Q1'25, Revenue: $127MQ1'25, Net income: $41MQ1'25Q2'25, Revenue: $137MQ2'25, Net income: $44MQ2'25Q3'25, Revenue: $169MQ3'25, Net income: $75MQ3'25Q4'25, Revenue: $138MQ4'25, Net income: $62MQ4'25Q1'26, Revenue: $146MQ1'26, Net income: $53MQ1'26Q2'26, Revenue: $169MQ2'26, Net income: $62MQ2'26Q3'26, Revenue: $185MQ3'26, Net income: $62MQ3'26Q4'26, Revenue: $145MQ4'26, Net income: $19MQ4'26Q1'27, Revenue: $157MQ1'27, Net income: $24MQ1'27Q2'27, Revenue: $175MQ2'27, Net income: $35MQ2'27$0$50M$100M$150M$200MQ3'23, Revenue: $115MQ3'23, Net income: $33MQ4'23, Revenue: $111MQ4'23, Net income: $31MQ4'23Q1'24, Revenue: $108MQ1'24, Net income: $28MQ2'24, Revenue: $114MQ2'24, Net income: $31MQ2'24Q3'24, Revenue: $135MQ3'24, Net income: $48MQ4'24, Revenue: $118MQ4'24, Net income: $41MQ4'24Q1'25, Revenue: $127MQ1'25, Net income: $41MQ2'25, Revenue: $137MQ2'25, Net income: $44MQ2'25Q3'25, Revenue: $169MQ3'25, Net income: $75MQ4'25, Revenue: $138MQ4'25, Net income: $62MQ4'25Q1'26, Revenue: $146MQ1'26, Net income: $53MQ2'26, Revenue: $169MQ2'26, Net income: $62MQ2'26Q3'26, Revenue: $185MQ3'26, Net income: $62MQ4'26, Revenue: $145MQ4'26, Net income: $19MQ4'26Q1'27, Revenue: $157MQ1'27, Net income: $24MQ2'27, Revenue: $175MQ2'27, Net income: $35MQ2'27

Net income losses drawn in red.

Free cash flow
$0$25M$50M$75M$100MQ3'23, Free cash flow: $48MQ3'23Q4'23, Free cash flow: $47MQ4'23Q1'24, Free cash flow: $57MQ1'24Q2'24, Free cash flow: $13MQ2'24Q3'24, Free cash flow: $50MQ3'24Q4'24, Free cash flow: $64MQ4'24Q1'25, Free cash flow: $41MQ1'25Q2'25, Free cash flow: $68MQ2'25Q3'25, Free cash flow: $65MQ3'25Q4'25, Free cash flow: $98MQ4'25Q1'26, Free cash flow: $62MQ1'26Q2'26, Free cash flow: $94MQ2'26Q3'26Q4'26Q1'27, Free cash flow: $42MQ1'27Q2'27, Free cash flow: $93MQ2'27$0$25M$50M$75M$100MQ3'23, Free cash flow: $48MQ3'23Q4'23, Free cash flow: $47MQ4'23Q1'24, Free cash flow: $57MQ1'24Q2'24, Free cash flow: $13MQ2'24Q3'24, Free cash flow: $50MQ3'24Q4'24, Free cash flow: $64MQ4'24Q1'25, Free cash flow: $41MQ1'25Q2'25, Free cash flow: $68MQ2'25Q3'25, Free cash flow: $65MQ3'25Q4'25, Free cash flow: $98MQ4'25Q1'26, Free cash flow: $62MQ1'26Q2'26, Free cash flow: $94MQ2'26Q3'26Q4'26Q1'27, Free cash flow: $42MQ1'27Q2'27, Free cash flow: $93MQ2'27$0$25M$50M$75M$100MQ3'23, Free cash flow: $48MQ4'23, Free cash flow: $47MQ4'23Q1'24, Free cash flow: $57MQ2'24, Free cash flow: $13MQ2'24Q3'24, Free cash flow: $50MQ4'24, Free cash flow: $64MQ4'24Q1'25, Free cash flow: $41MQ2'25, Free cash flow: $68MQ2'25Q3'25, Free cash flow: $65MQ4'25, Free cash flow: $98MQ4'25Q1'26, Free cash flow: $62MQ2'26, Free cash flow: $94MQ2'26Q4'26Q1'27, Free cash flow: $42MQ2'27, Free cash flow: $93MQ2'27

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$100M$200M$300M$400MQ3'23, Cash and equivalents: $136MQ3'23Q4'23, Cash and equivalents: $158MQ4'23Q1'24, Cash and equivalents: $307MQ1'24Q2'24, Cash and equivalents: $108MQ2'24Q3'24, Cash and equivalents: $123MQ3'24Q4'24, Cash and equivalents: $97MQ4'24Q1'25, Cash and equivalents: $111MQ1'25Q2'25, Cash and equivalents: $184MQ2'25Q3'25, Cash and equivalents: $165MQ3'25Q4'25, Cash and equivalents: $210MQ4'25Q1'26, Cash and equivalents: $137MQ1'26Q2'26, Cash and equivalents: $169MQ2'26Q3'26, Cash and equivalents: $65MQ3'26Q4'26, Cash and equivalents: $219MQ4'26Q1'27, Cash and equivalents: $274MQ1'27Q2'27, Cash and equivalents: $219MQ2'27$0$100M$200M$300M$400MQ3'23, Cash and equivalents: $136MQ3'23Q4'23, Cash and equivalents: $158MQ4'23Q1'24, Cash and equivalents: $307MQ1'24Q2'24, Cash and equivalents: $108MQ2'24Q3'24, Cash and equivalents: $123MQ3'24Q4'24, Cash and equivalents: $97MQ4'24Q1'25, Cash and equivalents: $111MQ1'25Q2'25, Cash and equivalents: $184MQ2'25Q3'25, Cash and equivalents: $165MQ3'25Q4'25, Cash and equivalents: $210MQ4'25Q1'26, Cash and equivalents: $137MQ1'26Q2'26, Cash and equivalents: $169MQ2'26Q3'26, Cash and equivalents: $65MQ3'26Q4'26, Cash and equivalents: $219MQ4'26Q1'27, Cash and equivalents: $274MQ1'27Q2'27, Cash and equivalents: $219MQ2'27$0$100M$200M$300M$400MQ3'23, Cash and equivalents: $136MQ4'23, Cash and equivalents: $158MQ4'23Q1'24, Cash and equivalents: $307MQ2'24, Cash and equivalents: $108MQ2'24Q3'24, Cash and equivalents: $123MQ4'24, Cash and equivalents: $97MQ4'24Q1'25, Cash and equivalents: $111MQ2'25, Cash and equivalents: $184MQ2'25Q3'25, Cash and equivalents: $165MQ4'25, Cash and equivalents: $210MQ4'25Q1'26, Cash and equivalents: $137MQ2'26, Cash and equivalents: $169MQ2'26Q3'26, Cash and equivalents: $65MQ4'26, Cash and equivalents: $219MQ4'26Q1'27, Cash and equivalents: $274MQ2'27, Cash and equivalents: $219MQ2'27

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2027 filed November 5, 2026.

Doximity, Inc. income statement, quarterly
Millions of dollarsQ2 FY2027ended Sep 30, 2026filed Nov 5, 2026Q1 FY2027ended Jun 30, 2026filed Aug 6, 2026Q4 FY2026ended Mar 31, 2026filed May 19, 2026Q3 FY2026ended Dec 31, 2025filed Feb 5, 2026Q2 FY2026ended Sep 30, 2025filed Nov 6, 2025Q1 FY2026ended Jun 30, 2025filed Aug 7, 2025Q4 FY2025ended Mar 31, 2025filed May 20, 2025Q3 FY2025ended Dec 31, 2024filed Feb 6, 2025YoYQ2 FY2027vs Q2 FY2026
Revenue175157145185169146138169+3.6%
Cost of revenue2524191916161414+54.3%
Gross profit149133126166152130124154−1.9%
Research and development4238393530272522+38.9%
Selling, general and administrative1616161819121314−13.8%
Operating income4434257264554980−31.0%
Other income (expense)67799101010−30.8%
Pretax income5040328173645890−31.0%
Income tax161613191111(4)15+43.4%
Net income3524196262536275−44.0%
Diluted EPS ($)0.180.13—0.310.310.27—0.37−41.9%
Diluted shares (millions)188191—199201201—202—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2027 filed November 5, 2026.

Doximity, Inc. balance sheet, quarterly
Millions of dollarsQ2 FY2027ended Sep 30, 2026filed Nov 5, 2026Q1 FY2027ended Jun 30, 2026filed Aug 6, 2026Q4 FY2026ended Mar 31, 2026filed May 19, 2026Q3 FY2026ended Dec 31, 2025filed Feb 5, 2026Q2 FY2026ended Sep 30, 2025filed Nov 6, 2025Q1 FY2026ended Jun 30, 2025filed Aug 7, 2025Q4 FY2025ended Mar 31, 2025filed May 20, 2025Q3 FY2025ended Dec 31, 2024filed Feb 6, 2025YoYQ2 FY2027vs Q2 FY2026
Cash and equivalents21927421965169137210165+29.2%
Short-term investments—————————
Total current assets9229149449931,0921,0341,0891,013−15.6%
Total assets1,0921,0841,1241,1571,2571,2041,2641,172−13.2%
Total current liabilities145150155150140160156116+3.1%
Long-term debt—————————
Total debt—————————
Total liabilities163168173178162179182141+1.1%
Stockholders’ equity9289169519791,0961,0261,0831,031−15.2%
Shares outstanding (millions)—————————

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2027 filed November 5, 2026.

Doximity, Inc. cash flow statement, quarterly
Millions of dollarsQ2 FY2027ended Sep 30, 2026filed Nov 5, 2026Q1 FY2027ended Jun 30, 2026filed Aug 6, 2026Q4 FY2026ended Mar 31, 2026filed May 19, 2026Q3 FY2026ended Dec 31, 2025filed Feb 5, 2026Q2 FY2026ended Sep 30, 2025filed Nov 6, 2025Q1 FY2026ended Jun 30, 2025filed Aug 7, 2025Q4 FY2025ended Mar 31, 2025filed May 20, 2025Q3 FY2025ended Dec 31, 2024filed Feb 6, 2025YoYQ2 FY2027vs Q2 FY2026
Operating cash flow93421106194629865−0.7%
Capital expenditures00——0000—
Free cash flow (CFO − capex)9342——94629865−0.7%
Depreciation and amortization44443333+25.5%
Share repurchases549291197221222719+147.6%
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2026 filed May 19, 2026.

Income statement

Doximity, Inc. income statement, annual
Millions of dollarsFY2026ended Mar 31, 2026filed May 19, 2026FY2025ended Mar 31, 2025filed May 20, 2025FY2024ended Mar 31, 2024filed May 23, 2024FY2023ended Mar 31, 2023filed May 26, 2023FY2022ended Mar 31, 2022filed May 27, 2022FY2021ended Mar 31, 2021filed Aug 12, 2021FY2020ended Mar 31, 2020filed Aug 12, 2021
Revenue645570475419344207116
Cost of revenue70565153403115
Gross profit575515425366304176101
Research and development131938280624432
Selling, general and administrative6546383736167
Operating income2152281641251145322
Other income (expense)3536210041
Pretax income2502641851331145824
Income tax54403820(41)8(6)
Net income1962231481131555030
Diluted EPS ($)0.981.110.720.530.700.230.13
Diluted shares (millions)1992012062131919582

Balance sheet

Doximity, Inc. balance sheet, annual
Millions of dollarsFY2026ended Mar 31, 2026filed May 19, 2026FY2025ended Mar 31, 2025filed May 20, 2025FY2024ended Mar 31, 2024filed May 23, 2024FY2023ended Mar 31, 2023filed May 26, 2023FY2022ended Mar 31, 2022filed May 27, 2022FY2021ended Mar 31, 2021filed Aug 12, 2021FY2020ended Mar 31, 2020filed Aug 12, 2021
Cash and equivalents2192109715811366—
Short-term investments———————
Total current assets9441,089913975904209—
Total assets1,1241,2641,0791,137991252—
Total current liabilities155156147140111102—
Long-term debt———————
Total debt———————
Total liabilities173182178171113104—
Stockholders’ equity9511,083901966879671
Shares outstanding (millions)———————

Cash flow statement

Doximity, Inc. cash flow statement, annual
Millions of dollarsFY2026ended Mar 31, 2026filed May 19, 2026FY2025ended Mar 31, 2025filed May 20, 2025FY2024ended Mar 31, 2024filed May 23, 2024FY2023ended Mar 31, 2023filed May 26, 2023FY2022ended Mar 31, 2022filed May 27, 2022FY2021ended Mar 31, 2021filed Aug 12, 2021FY2020ended Mar 31, 2020filed Aug 12, 2021
Operating cash flow3262731841801278326
Capital expenditures0002200
Free cash flow (CFO − capex)3262731841781258326
Depreciation and amortization14111010541
Share repurchases43212028185320
Dividends paid———————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$770K
8 sales by 4 insiders; officers and directors $770K
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$2M
22 sales by 4 insiders; officers and directors $2M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Nov 5, 2026Cabral Timothy SDirectorconversion7,500——18,805Nov 9, 2026
Nov 5, 2026Cabral Timothy SDirectoropen-market sale10b5-110,721$35.00$375K8,084Nov 9, 2026
Nov 2, 2026Wampler Kira SchererDirectorconversion2,000——29,923Nov 4, 2026
Nov 2, 2026Wampler Kira SchererDirectoropen-market sale10b5-12,000$32.89$66K27,923Nov 4, 2026
Oct 14, 2026Sitaram SiddharthChief Accounting Officerconversion8,000——104,045Oct 16, 2026
Oct 14, 2026Sitaram SiddharthChief Accounting Officeropen-market sale10b5-12,613$30.68$80K101,432Oct 16, 2026
Oct 1, 2026Wampler Kira SchererDirectorconversion2,000——29,923Oct 5, 2026
Oct 1, 2026Wampler Kira SchererDirectoropen-market sale10b5-12,000$28.91$58K27,923Oct 5, 2026
Sep 30, 2026Yang Watkin Phoebe L.Directoropen-market sale10b5-11,290$26.71$34K24,744Oct 2, 2026
Sep 24, 2026Zatz Steven LPresidentaward48,927$0.00—100,791Sep 28, 2026
Sep 24, 2026Zatz Steven LPresidentaward103,500$0.00—204,291Sep 28, 2026
Sep 15, 2026Sitaram SiddharthChief Accounting Officerconversion5,000——98,122Sep 16, 2026
Sep 15, 2026Sitaram SiddharthChief Accounting Officeropen-market sale10b5-12,077$26.02$54K96,045Sep 16, 2026
Sep 1, 2026Wampler Kira SchererDirectorconversion2,000——29,923Sep 3, 2026
Sep 1, 2026Wampler Kira SchererDirectoropen-market sale10b5-12,000$26.33$53K27,923Sep 3, 2026
Aug 27, 2026Spain KevinDirectoraward8,084$0.00—11,305Aug 31, 2026
Aug 27, 2026Yang Watkin Phoebe L.Directoraward8,084$0.00—26,034Aug 31, 2026
Aug 27, 2026Wampler Kira SchererDirectoraward8,084$0.00—27,923Aug 31, 2026
Aug 27, 2026Cabral Timothy SDirectoraward8,084$0.00—11,305Aug 31, 2026
Aug 27, 2026Benjamin Regina M.Directoraward8,084$0.00—58,987Aug 31, 2026
Aug 25, 2026Wampler Kira SchererDirectorconversion2,000——21,839Aug 27, 2026
Aug 25, 2026Wampler Kira SchererDirectoropen-market sale10b5-12,000$24.95$50K19,839Aug 27, 2026
Aug 15, 2026Sitaram SiddharthChief Accounting Officertax withholding3,882$24.80$96K93,122Aug 17, 2026
Aug 15, 2026Sonefeldt MatthewChief Financial Officertax withholding15,311$24.80$380K486,238Aug 17, 2026
Aug 15, 2026Zatz Steven LPresidenttax withholding4,482$24.80$111K51,864Aug 17, 2026

Full insider history for Doximity, Inc., or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

2 of the tracked managers held DOCS in their latest 13F filing, through November 16, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded DOCS by quarter.

FundManagerQuarterValueSharesWeightMove
FundsmithTerry SmithQ3 2026$12M436,5010.10%trimmed −33.2%
Renaissance TechnologiesPeter BrownQ3 2026$76M3M0.10%trimmed −5.9%

Sources

Fiscal year ends in month 3; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
Doximity, Inc., CIK 1516513 on EDGAR
Extract generated
November 16, 2026
Withheld
none
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue: CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: not filed
Total debt: not filed
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): not filed

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/DOCS.json